Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0YP7A
|
|||
| Drug Name |
Isothiocyanate derivative 1
|
|||
| Synonyms |
PMID26560530-Compound-9
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
Medicis Corp
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C3H4N2OS
|
|||
| Canonical SMILES |
C(C(=O)N)N=C=S
|
|||
| InChI |
1S/C3H4N2OS/c4-3(6)1-5-2-7/h1H2,(H2,4,6)
|
|||
| InChIKey |
LXDZRHJIMQYSSD-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tissue transglutaminase (TG2) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Tissue transglutaminase (TG2) | Target's Patent Info | [1] | |
| KEGG Pathway | Huntington's disease | |||
| Pathway Interaction Database | Beta1 integrin cell surface interactions | |||
| Thromboxane A2 receptor signaling | ||||
| Alpha9 beta1 integrin signaling events | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Transglutaminase inhibitors: a patent review.Expert Opin Ther Pat. 2016;26(1):49-63. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.